What is the price target for USM stock?
9 analysts have analysed USM and the average price target is 76.61 USD. This implies a price decrease of -0.52% is expected in the next year compared to the current price of 77.01.
US CELLULAR CORP (USM) Forecast, Price Target & Analyst Ratings
NYSE:USM • US9116841084
Current stock price
77.01 USD
+2.76 (+3.72%)
At close:
77.9 USD
+0.89 (+1.16%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for US CELLULAR CORP (USM).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- Oct 30, 2025
- Period
- Q3 / 2025
- EPS Estimate
- $0.31
- Revenue Estimate
- 917.27M
Price Target Details & History
Consensus Price Target and Range
Mean target
$76.61
Upside
-0.52%
From current price of $77.01 to mean target of $76.61, Based on 9 analyst forecasts
Low
$59.91
Median
$83.64
High
$88.20
Price Target Revisions
1 Month
2.74%
3 Months
1.35%
Price Target Summary
9 Wall Street analysts provided a forecast for the next 12 months for USM. The average price target is 76.61 USD. This implies a price decrease of -0.52% is expected in the next year compared to the current price of 77.01.
The average price target has been revised upward by 1.35% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
75.56%
USM was analyzed by 9 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about USM.
In the previous month the buy percentage consensus was at a similar level.
USM was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-08-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-25 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-05-28 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-05 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-02-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-11-07 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2024-11-04 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2024-05-30 | Wells Fargo | Upgrade | Equal-Weight -> Overweight |
| 2024-05-29 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-05-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2023-09-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-08-09 | Wells Fargo | Upgrade | Underweight -> Equal-Weight |
| 2023-08-08 | JP Morgan | Upgrade | Neutral -> Overweight |
| 2023-07-26 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-07-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-08 | Wells Fargo | Maintains | Underweight |
| 2023-02-07 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-01-10 | Wells Fargo | Downgrade | Overweight -> Underweight |
| 2022-11-08 | JP Morgan | Upgrade | Underweight -> Neutral |
| 2022-11-07 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2022-08-08 | Raymond James | Maintains | Strong Buy |
| 2022-05-09 | Raymond James | Maintains | Strong Buy |
| 2022-04-19 | Morgan Stanley | Downgrade | Overweight -> Equal-Weight |
| 2022-02-22 | Wells Fargo | Maintains | Overweight |
| 2022-02-22 | Raymond James | Maintains | Strong Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Oct 30, 2025
- Period
- Q3 / 2025
- EPS Estimate
- $0.31
- Revenue Estimate
- 917.27M
- Revenue Q2Q
- -0.51%
- EPS Q2Q
- 20.42%
- Number of Analysts
- 5
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.26%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
USM is expected to report earnings on 10/30/2025. The consensus EPS estimate for the next earnings is 0.31 USD and the consensus revenue estimate is 917.27M USD.
The next earnings revenue estimate has been revised upward by 0.26% in the past 3 months.
Full Analyst Estimates 2025 - 2029
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.169B 1.14% | 3.906B -6.31% | 3.77B -3.48% | 3.696B -1.96% | 3.697B 0.03% | 3.683B -0.38% | 220.18M -94.02% | 236.34M 7.34% | |
| EBITDA YoY % growth | 790M -9.09% | 810M 2.53% | 810M | 940.07M 16.06% | 932.22M -0.84% | 888.62M -4.68% | 113.12M -87.27% | 125.24M 10.71% | |
| EBIT YoY % growth | 90M -52.88% | 154M 71.11% | 145M -5.84% | 135.56M -6.51% | 159.73M 17.83% | 51.482M -67.77% | 97.97M 90.30% | 110.09M 12.37% | |
| Operating Margin | 2.16% | 3.94% | 3.85% | 3.67% | 4.32% | 1.40% | 44.50% | 46.58% | |
| EPS YoY % growth | 0.34 -80.79% | 0.62 82.35% | 0.71 14.52% | 0.82 15.94% | 1.11 34.97% | 1.26 13.64% | 0.63 -50.40% | 0.72 14.52% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.31 20.42% | 0.17 233.30% | 0.35 68.33% | 0.42 17.83% | 0.43 38.71% | 0.05 -69.70% |
| Revenue Q2Q % growth | 917.27M -0.51% | 959.3M -1.10% | 939.8M 5.48% | 927.31M 1.23% | 935.18M 1.95% | 967.35M 0.84% |
| EBITDA Q2Q % growth | 245.7M -55.08% | 198.58M -69.87% | 248.64M 21.29% | 256.3M 4.47% | 256.79M 4.51% | 196.19M -1.20% |
| EBIT Q2Q % growth | 43.37M -9.65% | -1.978M 67.03% | 39.552M -5.83% | 41.053M -13.23% | 35.758M -17.55% | -20.831M -953.01% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
21.15%
EPS Next 5 Year
0.20%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
-1.07%
Revenue Next 5 Year
-42.63%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
476.60%
EBIT Next 5 Year
95.74%
US CELLULAR CORP / USM Forecast FAQ
What is the next earnings date for USM stock?
US CELLULAR CORP (USM) will report earnings on 2025-10-30, before the market open.
What are the consensus estimates for US CELLULAR CORP (USM) next earnings?
The consensus EPS estimate for the next earnings of US CELLULAR CORP (USM) is 0.31 USD and the consensus revenue estimate is 917.27M USD.
What is the consensus rating for USM stock?
The consensus rating for US CELLULAR CORP (USM) is 75.5556 / 100 . This indicates that analysts generally have a positive outlook on the stock.